We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
+4.38%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$567M
AUM Growth
+$17.2M
Cap. Flow
+$1.05M
Cap. Flow %
0.19%
Top 10 Hldgs %
26.48%
Holding
199
New
9
Increased
67
Reduced
61
Closed
15

Top Buys

Rank Stock Value
1
HSY icon
Hershey
HSY
+$13.1M
2
PX
Praxair Inc
PX
+$4.09M
3
DIS icon
Walt Disney
DIS
+$3.29M
4
META icon
Meta Platforms (Facebook)
META
+$3.25M
5
DHR icon
Danaher
DHR
+$2.96M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$8.14M
2
PG icon
Procter & Gamble
PG
+$6.45M
3
CVS icon
CVS Health
CVS
+$5.02M
4
MDT icon
Medtronic
MDT
+$4.36M
5
PRGO icon
Perrigo
PRGO
+$4.15M

Sector Composition

Rank Sector Weight
1 Technology 17.28%
2 Healthcare 15.71%
3 Financials 15.64%
4 Consumer Staples 9.48%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FPRX
151
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$251K 0.04%
5,000
– –
WMB icon
152
Williams Companies
WMB
$86.1B
$249K 0.04%
8,000
-109
-1% -$3.29K
KKR icon
153
KKR & Co
KKR
$95.7B
$246K 0.04%
+16,000
New +$241K
PGEN icon
154
Precigen
PGEN
$2.36B
$243K 0.04%
10,090
– –
EBAY icon
155
eBay
EBAY
$47.6B
$226K 0.04%
7,628
+663
+10% +$19.6K
ZTS icon
156
Zoetis
ZTS
$32.3B
$224K 0.04%
+4,186
New +$213K
LNT icon
157
Alliant Energy
LNT
$18.4B
$220K 0.04%
5,813
-34
-0.6% -$1.25K
HPQ icon
158
HP
HPQ
$24.8B
$179K 0.03%
12,050
– –
ITCI
159
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$167K 0.03%
11,060
-29,290
-73% -$414K
PSTB
160
DELISTED
Park Sterling Corp.
PSTB
$166K 0.03%
15,384
– –
ATRA icon
161
Atara Biotherapeutics
ATRA
$77M
$153K 0.03%
432
+32
+8% +$13.5K
CEMP
162
DELISTED
Cempra, Inc.
CEMP
$127K 0.02%
45,250
-2,100
-4% -$25.5K
VIRX
163
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$121K 0.02%
952
– –
TOVX icon
164
Theriva Biologics
TOVX
$10.2M
$96K 0.02%
14
– –
FTR
165
DELISTED
Frontier Communications Corp.
FTR
$69K 0.01%
1,371
+34
+3% +$1.86K
SCPX
166
DELISTED
Scorpius Holdings, Inc.
SCPX
– –
0
– –
RIGL icon
167
Rigel Pharmaceuticals
RIGL
$693M
$48K 0.01%
2,000
– –
PDLI
168
DELISTED
PDL BioPharma, Inc.
PDLI
$48K 0.01%
22,500
– –
FCSC
169
DELISTED
Fibrocell Science Inc.
FCSC
$32K 0.01%
3,333
– –
MTEM
170
DELISTED
Molecular Templates, Inc.
MTEM
$31K 0.01%
424
– –
ACN icon
171
Accenture
ACN
$101B
– –
-1,639
Closed -$200K
CVS icon
172
CVS Health
CVS
$134B
– –
-56,393
Closed -$5.02M
JCI icon
173
Johnson Controls International
JCI
$88.7B
– –
-5,014
Closed -$233K
JWN
174
DELISTED
Nordstrom
JWN
– –
-45,188
Closed -$2.34M
LOB icon
175
Live Oak Bancshares
LOB
$2.03B
– –
-17,975
Closed -$259K
4 5 6
7
8

Similar funds

CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
EFS
Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
OAM
Ostrum Asset Management Paris, France $1.78B AUM 27.8% 1-Year Est. Return

Franklin Street Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Franklin Street Advisors held 199 positions worth $567M, up 3.1% from $550M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Franklin Street Advisors's Q4 2016 filing shows 9 new, 67 increased, 61 reduced and 15 closed positions. Its largest new stake was Hershey: 132,510 shares worth $13.7M. The largest sale was Gilead Sciences, an estimated $8.14M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Franklin Street Advisors's largest Q4 2016 buy was Hershey: 132,510 shares worth $13.7M.
  • Franklin Street Advisors added most to Praxair Inc in Q4 2016, an estimated $4.09M increase.
  • Franklin Street Advisors's biggest Q4 2016 reduction was Gilead Sciences, cutting an estimated $8.14M.
  • Franklin Street Advisors fully exited CVS Health in Q4 2016, selling an estimated $5.02M.
  • Franklin Street Advisors's ten largest holdings make up 26% of its $567M portfolio in Q4 2016.
  • Franklin Street Advisors opened 9 new positions and closed 15 in Q4 2016.
  • Franklin Street Advisors's portfolio value rose 3.1% quarter-over-quarter to $567M.

Based on Franklin Street Advisors's 13F filing for Q4 2016, filed 10 Jan 2017.